financetom
Business
financetom
/
Business
/
LIC asks IRDAI's permission to hold Rs 5,000 crore NCD investments in Tata Sons, says report
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LIC asks IRDAI's permission to hold Rs 5,000 crore NCD investments in Tata Sons, says report
Oct 12, 2018 12:56 AM

State-owned Life Insurance Corporation of India (LIC) has sought permission from Insurance Regulatory and Development Authority of India (Irdai) to allow the life insurer to continue holding Rs 5,000 crore of Tata Sons debt, The Economic Times reported.

The insurer bought the non-convertible debentures issued by Tata Sons in the last few years, before the conglomerate became private in September 2017, of which LIC receives an annual interest on the securities. The insurance regulator does not allow insurers to subscribe to the financial instruments of private companies.

“We should be permitted to hold on to the securities of Tata Sons since we purchased these non-convertible debentures (NCD) over a longer period,” the insurer wrote to the regulator.

“We have asked all insurers to come up with their exposure in Tata Sons after it became a private company," an Irdai official told the paper.

Sources from the conglomerate told the paper the group was aware of the buyback that it would have to undertake if LIC was not given an approval to hold the debt.

"In 2017, we have discussed with Tata shareholders the impact of going private and the financial repercussions,” unnamed sources told the daily, "The LIC disinvestment was part of that."

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cryoport Unit MVE Registers Manufacturing Facilities With FDA
Cryoport Unit MVE Registers Manufacturing Facilities With FDA
Jan 6, 2025
11:15 AM EST, 01/06/2025 (MT Newswires) -- Cryoport ( CYRX ) said Monday that its MVE Biological Solutions unit has registered its three manufacturing facilities with the US Food and Drug Administration. The company said that all applicable cryogenic freezers and dewars manufactured by MVE are now listed with the FDA. Cryoport ( CYRX ) shares were up 1.4% in...
Why AEON Biopharma Stock Is Down 65% Today
Why AEON Biopharma Stock Is Down 65% Today
Jan 6, 2025
AEON Biopharma Inc ( AEON ) shares are trading lower by 65% to 19 cents during Monday’s session after the company announced the pricing of a $20 million offering of 40 million units at 50 cents per unit. The funds will support AEON's development of ABP-450, a biosimilar to BOTOX for therapeutic use and enable comparative studies under the 351(k) pathway. CEO Marc Forth...
OSI Systems Secures $27 Million Order for Screening Solutions
OSI Systems Secures $27 Million Order for Screening Solutions
Jan 6, 2025
11:23 AM EST, 01/06/2025 (MT Newswires) -- OSI Systems ( OSIS ) said Monday that its security division received an order for about $27 million from an international customer for checkpoint and hold baggage screening products. The order includes Real Time Tomography 110 explosive detection system, Orion 920 Computed Tomography checkpoint screening system integrated with Rapiscan tray return system, Orion...
Ingredion Stops Operations at Manufacturing Facility in Vanscoy, Canada
Ingredion Stops Operations at Manufacturing Facility in Vanscoy, Canada
Jan 6, 2025
11:19 AM EST, 01/06/2025 (MT Newswires) -- Ingredion ( INGR ) said Monday it has stopped operations at its plant protein manufacturing facility in Vanscoy, Canada, affecting about 20 employees. The company said it intends to sell the facility and the property, though it has yet to enter into a sale agreement. Ingredion ( INGR ) expects to book about...
Copyright 2023-2026 - www.financetom.com All Rights Reserved